Nutra Pharma Corp
Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases in the United States. The company offers Nyloxin, an over-the-counter (OTC) pain reliever; Nyloxin Extra Strength, a non-narcotic and non-addictive treatment fo… Read more
Market Cap & Net Worth: Nutra Pharma Corp (NPHC)
Nutra Pharma Corp (PINK:NPHC) has a market capitalization of $1.42 Million ($1.42 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #35238 globally and #11485 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nutra Pharma Corp's stock price $0.00 by its total outstanding shares 7099727214 (7.10 Billion).
Nutra Pharma Corp Market Cap History: 2015 to 2025
Nutra Pharma Corp's market capitalization history from 2015 to 2025. Data shows change from $394.03 Million to $1.42 Million (-47.85% CAGR).
Nutra Pharma Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nutra Pharma Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.24x
Nutra Pharma Corp's market cap is 3.24 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
0.17x
Nutra Pharma Corp's market cap is 0.17 times its annual earnings
10.35x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $394.03 Million | $291.30K | -$5.39 Million | 1352.67x | N/A |
| 2016 | $58.22 Million | $168.36K | -$3.45 Million | 345.80x | N/A |
| 2017 | $4.97 Million | $120.98K | -$4.03 Million | 41.08x | N/A |
| 2018 | $2.13 Million | $-1.88 Million | -$3.88 Million | -1.14x | N/A |
| 2019 | $3.55 Million | $104.39K | -$6.59 Million | 34.00x | N/A |
| 2020 | $8.52 Million | $104.39K | -$6.59 Million | 81.61x | N/A |
| 2021 | $14.20 Million | $97.73K | -$13.10 Million | 145.29x | N/A |
| 2022 | $709.97K | $438.27K | $8.18 Million | 1.62x | 0.09x |
| 2025 | $1.42 Million | $438.27K | $8.18 Million | 3.24x | 0.17x |
Competitor Companies of NPHC by Market Capitalization
Companies near Nutra Pharma Corp in the global market cap rankings as of March 19, 2026.
Key companies related to Nutra Pharma Corp by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Nutra Pharma Corp Historical Marketcap From 2015 to 2025
Between 2015 and today, Nutra Pharma Corp's market cap moved from $394.03 Million to $ 1.42 Million, with a yearly change of -47.85%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $1.42 Million | +100.00% |
| 2024 | $709.97K | 0.00% |
| 2022 | $709.97K | -95.00% |
| 2021 | $14.20 Million | +66.67% |
| 2020 | $8.52 Million | +140.00% |
| 2019 | $3.55 Million | +66.67% |
| 2018 | $2.13 Million | -57.14% |
| 2017 | $4.97 Million | -91.46% |
| 2016 | $58.22 Million | -85.23% |
| 2015 | $394.03 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Nutra Pharma Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.42 Million USD |
| MoneyControl | $1.42 Million USD |
| MarketWatch | $1.42 Million USD |
| marketcap.company | $1.42 Million USD |
| Reuters | $1.42 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.